Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B M Lomaestro

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Drug Safety|July 6, 2000
Fluoroquinolone-induced renal failureB M Lomaestro
Annals of Internal Medicine|April 1, 1990
Tissue plasminogen activator and heparin dosageB M Lomaestro
Drug Intelligence & Clinical Pharmacy|November 1, 1988
Ethylene glycol toxicity--misinterpretation of laboratory dataB M Lomaestro
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 31, 2001
Therapeutic interchange of fluoroquinolones at a medical centerB M Lomaestro
Annals of Internal Medicine|November 15, 1994
More on the GUSTO TrialB M Lomaestro
The Annals of Pharmacotherapy|December 1, 1995
Glutathione in health and disease: pharmacotherapeutic issuesB M Lomaestro, M Malone
Hospital Formulary|October 6, 1988
DUE (drug usage evaluation) of ticarcillin and clavulanate potassium: determining appropriate and cost-effective therapeutic optionsB M Lomaestro, T S Lesar
The Annals of Pharmacotherapy|November 1, 1993
Effect of multiple staggered doses of calcium on the bioavailability of ciprofloxacinB M Lomaestro, G R Bailie
American Journal of Hospital Pharmacy|March 15, 1994
Continuing problem of ciprofloxacin administered with interacting drugsB M Lomaestro, T S Lesar
Drugs & Aging|January 12, 1999
Streptogramins and their potential role in geriatric medicineB M Lomaestro, L L Briceland
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Drug Safety|July 6, 2000
Fluoroquinolone-induced renal failureB M Lomaestro
Annals of Internal Medicine|April 1, 1990
Tissue plasminogen activator and heparin dosageB M Lomaestro
Drug Intelligence & Clinical Pharmacy|November 1, 1988
Ethylene glycol toxicity--misinterpretation of laboratory dataB M Lomaestro
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 31, 2001
Therapeutic interchange of fluoroquinolones at a medical centerB M Lomaestro
Annals of Internal Medicine|November 15, 1994
More on the GUSTO TrialB M Lomaestro
The Annals of Pharmacotherapy|December 1, 1995
Glutathione in health and disease: pharmacotherapeutic issuesB M Lomaestro, M Malone
Hospital Formulary|October 6, 1988
DUE (drug usage evaluation) of ticarcillin and clavulanate potassium: determining appropriate and cost-effective therapeutic optionsB M Lomaestro, T S Lesar
The Annals of Pharmacotherapy|November 1, 1993
Effect of multiple staggered doses of calcium on the bioavailability of ciprofloxacinB M Lomaestro, G R Bailie
American Journal of Hospital Pharmacy|March 15, 1994
Continuing problem of ciprofloxacin administered with interacting drugsB M Lomaestro, T S Lesar
Drugs & Aging|January 12, 1999
Streptogramins and their potential role in geriatric medicineB M Lomaestro, L L Briceland
Pageof 3